{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:42:22Z","timestamp":1793108542469,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41375-026-03118-7","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:57:11Z","timestamp":1787554631000},"page":"2516-2529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2025-9667","authenticated-orcid":false,"given":"Lichang","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-3533","authenticated-orcid":false,"given":"Reagan Entigu Anak","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bertolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Mun","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Wen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Syn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho Mar","family":"Myint Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1333-407X","authenticated-orcid":false,"given":"Jin-Xin","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-5049","authenticated-orcid":false,"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1854-1481","authenticated-orcid":false,"given":"Susan Swee-Shan","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Poh Sheng","family":"Yeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4623-4633","authenticated-orcid":false,"given":"Li Yen","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Mei","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-4288","authenticated-orcid":false,"given":"Choon Kiat","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Quan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-5505","authenticated-orcid":false,"given":"Soon Thye","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9816-6137","authenticated-orcid":false,"given":"Anand Devaprasath","family":"Jeyasekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-6410","authenticated-orcid":false,"given":"Siok-Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"3118_CR1","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","volume":"35","author":"H Wang","year":"2021","unstructured":"Wang H, Fu BB, Gale RP, Liang Y. NK-\/T-cell lymphomas. Leukemia. 2021;35:2460\u20138.","journal-title":"Leukemia"},{"key":"3118_CR2","volume":"44","author":"J Tan","year":"2025","unstructured":"Tan J, Li Y, Hu L, Zhao Y, Yi W. Epstein-Barr virus LMP1 promotes tumorigenesis in a murine epithelial tumor model. Biochem Biophys Rep. 2025;44:102346.","journal-title":"Biochem Biophys Rep"},{"key":"3118_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-023-01483-9","volume":"16","author":"XP Tian","year":"2023","unstructured":"Tian XP, Cao Y, Cai J, Zhang YC, Zou QH, Wang JN, et al. Novel target and treatment agents for natural killer\/T-cell lymphoma. J Hematol Oncol. 2023;16:78.","journal-title":"J Hematol Oncol"},{"key":"3118_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-024-01825-0","volume":"9","author":"Y Gao","year":"2024","unstructured":"Gao Y, He H, Li X, Zhang L, Xu W, Feng R, et al. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib\/II study. Signal Transd Target Ther. 2024;9:121.","journal-title":"Signal Transd Target Ther"},{"key":"3118_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108192","volume":"26","author":"L He","year":"2023","unstructured":"He L, Chen N, Dai L, Peng X. Advances and challenges of immunotherapies in NK\/T cell lymphomas. iScience. 2023;26:108192.","journal-title":"iScience"},{"key":"3118_CR6","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1016\/S2352-3026(24)00066-8","volume":"11","author":"XP Tian","year":"2024","unstructured":"Tian XP, Cai J, Xia Y, Zhang YC, Wang L, Liu PP, et al. First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer\/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2024;11:e336\u201344.","journal-title":"Lancet Haematol"},{"key":"3118_CR7","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00277-023-05603-w","volume":"103","author":"M Qing","year":"2024","unstructured":"Qing M, Zhou T, Perova T, Abraham Y, Sweeney C, Krevvata M, et al. Immune profiling of patients with extranodal natural killer\/T cell lymphoma treated with daratumumab. Ann Hematol. 2024;103:1989\u20132001.","journal-title":"Ann Hematol"},{"key":"3118_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41379-019-0392-8","volume":"33","author":"J Cho","year":"2020","unstructured":"Cho J, Kim SJ, Park WY, Kim J, Woo J, Kim G, et al. Immune subtyping of extranodal NK\/T-cell lymphoma: a new biomarker and an immune shift during disease progression. Mod Pathol. 2020;33:603\u201315.","journal-title":"Mod Pathol"},{"key":"3118_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-022-01293-5","volume":"15","author":"E Tse","year":"2022","unstructured":"Tse E, Zhao WL, Xiong J, Kwong YL. How we treat NK\/T-cell lymphomas. J Hematol Oncol. 2022;15:74.","journal-title":"J Hematol Oncol"},{"key":"3118_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303913","volume":"10","author":"YQ Li","year":"2023","unstructured":"Li YQ, Luo CL, Jiang JX, He S, Liu Y, Yan WX, et al. Single-cell analysis reveals malignant cells reshape the cellular landscape and foster an immunosuppressive microenvironment of extranodal NK\/T-cell lymphoma. Adv Sci. 2023;10:e2303913.","journal-title":"Adv Sci"},{"key":"3118_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109235","volume":"112","author":"X Xiong","year":"2022","unstructured":"Xiong X, Xie X, Wang Z, Zhang Y, Wang L. Tumor-associated macrophages in lymphoma: From mechanisms to therapy. Int Immunopharmacol. 2022;112:109235.","journal-title":"Int Immunopharmacol"},{"key":"3118_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla G, Spitzer H, Klein M, Fischer D, Schaar AC, Kuemmerle LB, et al. Squidpy: a scalable framework for spatial omics analysis. Nat Methods. 2022;19:171\u20138.","journal-title":"Nat Methods"},{"key":"3118_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc. 2025;20:180\u2013219.","journal-title":"Nat Protoc"},{"key":"3118_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"3118_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt CR, Ong GT, Church SE, Barker K, Danaher P, Geiss G, et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38:586\u201399.","journal-title":"Nat Biotechnol"},{"key":"3118_CR16","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41587-022-01483-z","volume":"40","author":"S He","year":"2022","unstructured":"He S, Bhatt R, Brown C, Brown EA, Buhr DL, Chantranuvatana K, et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat Biotechnol. 2022;40:1794\u2013806.","journal-title":"Nat Biotechnol"},{"key":"3118_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46220-z","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Bertolazzi G, Sridhar S, Lee RX, Jaynes P, Mulder K, et al. Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma. Nat Commun. 2024;15:2113.","journal-title":"Nat Commun"},{"key":"3118_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49885-8","volume":"15","author":"A Coulton","year":"2024","unstructured":"Coulton A, Murai J, Qian D, Thakkar K, Lewis CE, Litchfield K. Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response. Nat Commun. 2024;15:5665.","journal-title":"Nat Commun"},{"key":"3118_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00660-4","volume":"8","author":"C Wei","year":"2024","unstructured":"Wei C, Ma Y, Wang M, Wang S, Yu W, Dong S, et al. Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census. NPJ Precis Oncol. 2024;8:176.","journal-title":"NPJ Precis Oncol"},{"key":"3118_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451018","volume":"54","author":"ND Zandhuis","year":"2024","unstructured":"Zandhuis ND, Guislain A, Popalzij A, Engels S, Popovi\u0107 B, Turner M, et al. Regulation of IFN-\u03b3 production by ZFP36L2 in T cells is time-dependent. Eur J Immunol. 2024;54:e2451018.","journal-title":"Eur J Immunol"},{"key":"3118_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41590-023-01430-3","volume":"24","author":"PS Liu","year":"2023","unstructured":"Liu PS, Chen YT, Li X, Hsueh PC, Tzeng SF, Chen H, et al. CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat Immunol. 2023;24:452\u201362.","journal-title":"Nat Immunol"},{"key":"3118_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32401-1","volume":"13","author":"WW Luo","year":"2022","unstructured":"Luo WW, Tong Z, Cao P, Wang FB, Liu Y, Zheng ZQ, et al. Transcription-independent regulation of STING activation and innate immune responses by IRF8 in monocytes. Nat Commun. 2022;13:4822.","journal-title":"Nat Commun"},{"key":"3118_CR23","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder K, Patel AA, Kong WT, Piot C, Halitzki E, Dunsmore G, et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity. 2021;54:1883\u2013900.e5.","journal-title":"Immunity"},{"key":"3118_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"3118_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792\u2013809.e23.","journal-title":"Cell"},{"key":"3118_CR26","doi-asserted-by":"publisher","first-page":"e007441","DOI":"10.1136\/jitc-2023-007441","volume":"11","author":"S Zhang","year":"2023","unstructured":"Zhang S, Peng W, Wang H, Xiang X, Ye L, Wei X, et al. C1q+ tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion. J Immunother Cancer. 2023;11:e007441.","journal-title":"J Immunother Cancer"},{"key":"3118_CR27","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, et al. Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res. 2022;82:3291\u2013306.","journal-title":"Cancer Res"},{"key":"3118_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1000497","volume":"14","author":"I Larionova","year":"2023","unstructured":"Larionova I, Kiselev A, Kazakova E, Liu T, Patysheva M, Iamshchikov P, et al. Tumor-associated macrophages respond to chemotherapy by detrimental transcriptional reprogramming and suppressing stabilin-1 mediated clearance of EGF. Front Immunol. 2023;14:1000497.","journal-title":"Front Immunol"},{"key":"3118_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53376-1","volume":"15","author":"J Koya","year":"2024","unstructured":"Koya J, Tanigawa T, Mizuno K, Kim H, Ito Y, Yuasa M, et al. Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets. Nat Commun. 2024;15:9106.","journal-title":"Nat Commun"},{"key":"3118_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong J, Cui BW, Wang N, Dai YT, Zhang H, Wang CF, et al. Genomic and transcriptomic characterization of natural killer T cell lymphoma. Cancer Cell. 2020;37:403\u201319.e6.","journal-title":"Cancer Cell"},{"key":"3118_CR31","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.scib.2023.09.029","volume":"68","author":"J Xiong","year":"2023","unstructured":"Xiong J, Dai YT, Wang WF, Zhang H, Wang CF, Yin T, et al. GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis. Sci Bull. 2023;68:2607\u201319.","journal-title":"Sci Bull"},{"key":"3118_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113626","volume":"28","author":"S Ma","year":"2025","unstructured":"Ma S, Huang B, Wang J, Lv R, Dai DL, Zhong Q, et al. Single-cell and spatial transcriptomics reveal intratumor heterogeneity and immune evasion in natural killer\/T cell lymphoma. iScience. 2025;28:113626.","journal-title":"iScience"},{"key":"3118_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102030","volume":"6","author":"YQ Wang","year":"2025","unstructured":"Wang YQ, Wang S, Yi HM, Qian Y, Wang Y, Xu HM, et al. Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology. Cell Rep Med. 2025;6:102030.","journal-title":"Cell Rep Med"},{"key":"3118_CR34","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","volume":"129","author":"YL Kwong","year":"2017","unstructured":"Kwong YL, Chan TSY, Tan D, Kim SJ, Poon LM, Mow B, et al. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase. Blood. 2017;129:2437\u201342.","journal-title":"Blood"},{"key":"3118_CR35","volume":"62","author":"WL Chan","year":"2025","unstructured":"Chan WL, Hue SSS, Deng L, Leong SM, Chng WJ, Ng SB. Extranodal NK\/T-cell lymphoma: an update of the molecular characterization of the tumor and microenvironment, and its clinical implications. Lancet Reg Health West Pac. 2025;62:101550.","journal-title":"Lancet Reg Health West Pac"},{"key":"3118_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48700-8","volume":"15","author":"M De Zuani","year":"2024","unstructured":"De Zuani M, Xue H, Park JS, Dentro SC, Seferbekova Z, Tessier J, et al. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nat Commun. 2024;15:4388.","journal-title":"Nat Commun"},{"key":"3118_CR37","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"Oliveira","year":"2025","unstructured":"Oliveira, de MF, Romero JP, Chung M, Williams SR, Gottscho AD, et al. High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat Genet. 2025;57:1512\u201323.","journal-title":"Nat Genet"},{"key":"3118_CR38","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1158\/1078-0432.CCR-18-3016","volume":"25","author":"M Viitala","year":"2019","unstructured":"Viitala M, Virtakoivu R, Tadayon S, Rannikko J, Jalkanen S, Hollm\u00e9n M. Immunotherapeutic blockade of macrophage Clever-1 reactivates the CD8+ T-cell response against immunosuppressive tumors. Clin Cancer Res. 2019;25:3289\u2013303.","journal-title":"Clin Cancer Res"},{"key":"3118_CR39","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1158\/1078-0432.CCR-20-4862","volume":"27","author":"R Virtakoivu","year":"2021","unstructured":"Virtakoivu R, Rannikko JH, Viitala M, Vaura F, Takeda A, L\u00f6nnberg T, et al. Systemic blockade of Clever-1 elicits lymphocyte activation alongside checkpoint molecule downregulation in patients with solid tumors: Results from a phase I\/II clinical trial. Clin Cancer Res. 2021;27:4205\u201320.","journal-title":"Clin Cancer Res"},{"key":"3118_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101307","volume":"4","author":"JH Rannikko","year":"2023","unstructured":"Rannikko JH, Verlingue L, de Miguel M, Pasanen A, Robbrecht D, Skytta T, et al. Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I\/II first-in-human MATINS trial. Cell Rep Med. 2023;4:101307.","journal-title":"Cell Rep Med"},{"key":"3118_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1816800","volume":"14","author":"L Huang","year":"2026","unstructured":"Huang L, Pan L, Qin W, Zhao Y, Huang Y, Qin X. SLC40A1 (iron transporter): mechanistic regulation, role in disease pathogenesis, and prospects for targeted therapy. Front Cell Dev Biol. 2026;14:1816800.","journal-title":"Front Cell Dev Biol"},{"key":"3118_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00109-025-02563-8","volume":"103","author":"J Lee","year":"2025","unstructured":"Lee J, Roh JL. Selenium and selenoproteins: key regulators of ferroptosis and therapeutic targets in cancer. J Mol Med. 2025;103:899\u2013911.","journal-title":"J Mol Med"},{"key":"3118_CR43","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1038\/s41588-025-02353-5","volume":"57","author":"Y Dai","year":"2025","unstructured":"Dai Y, Kizhakeyil A, Chihara D, Li X, Liu Y, Sainz Zuniga TP, et al. Multi-modal spatial characterization of tumor immune microenvironments identifies targetable inflammatory niches in diffuse large B cell lymphoma. Nat Genet. 2025;57:2715\u201327.","journal-title":"Nat Genet"},{"key":"3118_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/blood.2019000847","volume":"135","author":"J Kline","year":"2020","unstructured":"Kline J, Godfrey J, Ansell SM. The immune landscape and response to immune checkpoint blockade therapy in lymphoma. Blood. 2020;135:523\u201333.","journal-title":"Blood"},{"key":"3118_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M, Wang L, Chen X, Feng Y, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer. 2020;19:41.","journal-title":"Mol Cancer"},{"key":"3118_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1158\/2326-6066.CIR-22-0290","volume":"11","author":"R Diwanji","year":"2023","unstructured":"Diwanji R, O\u2019Brien NA, Choi JE, Nguyen B, Laszewski T, Grauel AL, et al. Targeting the IL1\u03b2 pathway for cancer immunotherapy remodels the tumor microenvironment and enhances antitumor immune responses. Cancer Immunol Res. 2023;11:777\u201391.","journal-title":"Cancer Immunol Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03118-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:58:40Z","timestamp":1793105920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03118-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3118"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03118-7","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors confirm that all methods were performed in accordance with the relevant institutional guidelines and regulations. The study was approved by the National Healthcare Group Domain Specific Review Board B (2009\/00212), with a waiver of informed consent to use archival FFPE tissue samples. No live vertebrate studies were performed. No identifiable images are included in this study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}